Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 37.48M
March 31, 2026 37.27M
December 31, 2025 37.23M
September 30, 2025 37.03M
June 30, 2025 36.71M
March 31, 2025 35.65M
December 31, 2024 35.62M
September 30, 2024 35.61M
June 30, 2024 35.48M
March 31, 2024 35.38M
December 31, 2023 35.17M
September 30, 2023 35.12M
June 30, 2023 30.28M
March 31, 2023 30.06M
December 31, 2022 29.90M
September 30, 2022 27.07M
June 30, 2022 27.07M
March 31, 2022 27.03M
December 31, 2021 26.90M
September 30, 2021 26.90M
June 30, 2021 26.89M
March 31, 2021 25.98M
December 31, 2020 25.75M
September 30, 2020 25.65M
June 30, 2020 25.65M
Date Value
March 31, 2020 25.62M
December 31, 2019 25.53M
September 30, 2019 25.17M
June 30, 2019 25.14M
March 31, 2019 24.72M
December 31, 2018 24.34M
September 30, 2018 22.66M
June 30, 2018 21.05M
March 31, 2018 20.81M
December 31, 2017 20.62M
September 30, 2017 20.17M
June 30, 2017 20.07M
March 31, 2017 19.97M
December 31, 2016 18.63M
September 30, 2016 13.23M
June 30, 2016 13.18M
March 31, 2016 13.11M
December 31, 2015 9.756M
September 30, 2015 9.682M
June 30, 2015 9.551M
March 31, 2015 9.354M
December 31, 2014 9.258M
September 30, 2014 9.247M
June 30, 2014 9.128M
March 31, 2014 9.086M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 1.155B
Zevra Therapeutics, Inc. 59.34M
Indivior Pharmaceuticals, Inc. 118.00M
Liquidia Corp. 89.10M
60 Degrees Pharmaceuticals, Inc. 2.659M